单纯疱疹性角膜炎治疗进展。
Update on Herpes simplex keratitis management.
机构信息
Cornea & External Diseases Service, Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, UK.
NIHR Moorfields Clinical Research Facility, Moorfields Eye Hospital, London, UK.
出版信息
Eye (Lond). 2020 Dec;34(12):2219-2226. doi: 10.1038/s41433-020-01153-x. Epub 2020 Aug 25.
Abstract
Herpes simplex keratitis (HSK) is a common, potentially blinding condition characterised by recurrent infections of the cornea, seen by both general ophthalmologists and corneal specialists. Successful treatment of recurrences reduces disease duration, prevents progressive corneal scaring leading to vision loss and reduces risk of further recurrences. In this review we discuss the relative advantages of the diagnostic laboratory investigations including polymerase chain reaction, viral culture and fluorescence-based immunohistochemistry. We review treatment strategies in selected aspects of HSK and discuss the management options in cases not responding to treatment.
摘要
单纯疱疹病毒性角膜炎（HSK）是一种常见的、潜在致盲性疾病，其特征为角膜反复感染，可由普通眼科医生和角膜专家共同诊断。成功治疗复发可缩短疾病持续时间，防止进行性角膜瘢痕导致视力丧失，并降低进一步复发的风险。在本综述中，我们讨论了包括聚合酶链反应、病毒培养和基于荧光的免疫组织化学在内的诊断实验室检查的相对优势。我们回顾了 HSK 某些方面的治疗策略，并讨论了治疗无效病例的处理选择。
相似文献
1
Update on Herpes simplex keratitis management.
Eye (Lond). 2020 Dec;34(12):2219-2226. doi: 10.1038/s41433-020-01153-x. Epub 2020 Aug 25.
2
Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes.
Ophthalmology. 2012 Oct;119(10):2003-8. doi: 10.1016/j.ophtha.2012.05.008. Epub 2012 Jul 13.
3
Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons.
Br J Ophthalmol. 2000 Nov;84(11):1238-43. doi: 10.1136/bjo.84.11.1238.
4
Comparison of an immortalized human corneal epithelial cell line with Vero cells in the isolation of Herpes simplex virus-1 for the laboratory diagnosis of Herpes simplex keratitis.
BMC Ophthalmol. 2002 Apr 30;2:3. doi: 10.1186/1471-2415-2-3.
5
A 20-year experience of ocular herpes virus detection using immunofluorescence and polymerase chain reaction.
Clin Exp Optom. 2018 Sep;101(5):648-651. doi: 10.1111/cxo.12669. Epub 2018 Mar 6.
6
Herpes keratitis.
Prog Retin Eye Res. 2013 Jan;32:88-101. doi: 10.1016/j.preteyeres.2012.08.002. Epub 2012 Aug 27.
7
[Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Nippon Ganka Gakkai Zasshi. 2008 Mar;112(3):247-64; discussion 265.
8
A systematic review on advances in diagnostics for herpes simplex keratitis.
Surv Ophthalmol. 2021 May-Jun;66(3):514-530. doi: 10.1016/j.survophthal.2020.09.008. Epub 2020 Nov 10.
9
Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts.
Cochrane Database Syst Rev. 2016 Nov 30;11(11):CD007824. doi: 10.1002/14651858.CD007824.pub2.
10
Management of Neonatal Herpes Simplex Infection: A Rare Case of Blepharoconjunctivitis and Concurrent Epithelial and Stromal Keratitis.
Ocul Immunol Inflamm. 2018;26(4):625-627. doi: 10.1080/09273948.2016.1242017. Epub 2016 Nov 16.
引用本文的文献
1
[Herpes simplex virus keratitis : S1 guidelines of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)].
Ophthalmologie. 2025 Sep 1. doi: 10.1007/s00347-025-02297-5.
2
CRISPR/Cas9 Reduces Viral Load in a BALB/c Mouse Model of Ocular Herpes Infection.
Biomedicines. 2025 Jul 16;13(7):1738. doi: 10.3390/biomedicines13071738.
3
Quercetin inhibits herpes simplex virus 1 replication in corneal epithelium and suppresses keratitis progression.
Virol Sin. 2025 Aug;40(4):647-657. doi: 10.1016/j.virs.2025.07.007. Epub 2025 Jul 15.
4
Herpes simplex keratitis in central India: Clinical types, treatment patterns, and outcome measures.
Indian J Ophthalmol. 2025 Jul 1;73(7):1050-1054. doi: 10.4103/IJO.IJO_2233_24. Epub 2025 Jun 30.
5
Luteolin alleviates Herpes Simplex Keratitis by inhibiting inflammatory responses via suppressing the PTGS2/NF-κB signaling pathway.
Am J Transl Res. 2025 May 15;17(5):3307-3321. doi: 10.62347/IQUZ8416. eCollection 2025.
6
Global research trend of Herpes simplex keratitis: a bibliometric analysis and visualization from 1941 to 2024.
Front Med (Lausanne). 2025 Mar 19;12:1526116. doi: 10.3389/fmed.2025.1526116. eCollection 2025.
7
Herpes Simplex Keratitis and Vitamin D Receptor Agonist: Two Case Reports.
Diseases. 2025 Jan 30;13(2):38. doi: 10.3390/diseases13020038.
8
Tear metabolomics reveals novel potential biomarkers in epithelial herpes simplex keratitis.
BMC Ophthalmol. 2025 Jan 23;25(1):43. doi: 10.1186/s12886-025-03875-6.
9
The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis.
Clin Microbiol Rev. 2024 Sep 12;37(3):e0000624. doi: 10.1128/cmr.00006-24. Epub 2024 Jul 30.
10
Retinoic Acid Neutralizes the Effects of Herpes Simplex Virus Type 1-Infected Cell Protein 0 (ICP0) in Retinal Pigment Epithelial Cells.
Cureus. 2024 May 26;16(5):e61089. doi: 10.7759/cureus.61089. eCollection 2024 May.
本文引用的文献
1
Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial.
Ophthalmology. 2020 Jan;127(1):14-26. doi: 10.1016/j.ophtha.2019.08.020. Epub 2019 Aug 26.
2
Neurotrophic keratopathy.
Prog Retin Eye Res. 2018 Sep;66:107-131. doi: 10.1016/j.preteyeres.2018.04.003. Epub 2018 Apr 23.
3
Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study.
J Dermatol. 2017 Nov;44(11):1219-1227. doi: 10.1111/1346-8138.13948. Epub 2017 Jul 5.
4
Persistent Impairment of Quality of Life in Patients with Herpes Simplex Keratitis.
Ophthalmology. 2017 Feb;124(2):160-169. doi: 10.1016/j.ophtha.2016.10.001. Epub 2016 Nov 15.
5
Implementation and Evaluation of a Fully Automated Multiplex Real-Time PCR Assay on the BD Max Platform to Detect and Differentiate Herpesviridae from Cerebrospinal Fluids.
PLoS One. 2016 Apr 19;11(4):e0153991. doi: 10.1371/journal.pone.0153991. eCollection 2016.
6
Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.
PLoS One. 2015 Oct 28;10(10):e0140765. doi: 10.1371/journal.pone.0140765. eCollection 2015.
7
Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.
Nat Commun. 2015 Apr 27;6:6985. doi: 10.1038/ncomms7985.
8
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.
Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD002898. doi: 10.1002/14651858.CD002898.pub5.
9
Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization.
Ophthalmology. 2015 Jun;122(6):1079-84. doi: 10.1016/j.ophtha.2015.02.012. Epub 2015 Apr 1.
10
Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.
PLoS One. 2015 Jan 21;10(1):e114989. doi: 10.1371/journal.pone.0114989. eCollection 2015.
Zotero 插件